Supported in part by research grants from Shanghai Science and Technology Committee (14411965500), The Natural Science Foundation of Shanghai Municipal Science and Technology Commission (13ZR1406100), Shanghai Key Laboratory of Visual Impairment and Restoration, National Institutes of Health (NIH; Bethesda, MD, USA) Grants DP3 DK104397, R01EY024544, R01EY023285, P30 EY010572, and an unrestricted grant from Research to Prevent Blindness. Oregon Health & Science University (OHSU), David Huang and Yali Jia have a significant financial interest in Optovue, Inc. David Huang also has a financial interest in Carl Zeiss Meditec, Inc. These potential conflicts of interest have been reviewed and managed by OHSU.
Disclosure: M. Wang, None; Y. Zhou, None; S.S. Gao, None; W. Liu, None; Y. Huang, None; D. Huang, Optovue, Inc. (F, I, R), P, Carl Zeiss Meditec, Inc. P; Y. Jia, Optovue, Inc. (F), P